clomipramine has been researched along with Schizotypal Personality Disorder in 1 studies
Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.
Schizotypal Personality Disorder: A personality disorder in which there are oddities of thought (magical thinking, paranoid ideation, suspiciousness), perception (illusions, depersonalization), speech (digressive, vague, overelaborate), and behavior (inappropriate affect in social interactions, frequently social isolation) that are not severe enough to characterize schizophrenia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ravizza, L | 1 |
| Barzega, G | 1 |
| Bellino, S | 1 |
| Bogetto, F | 1 |
| Maina, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical, Neurocognitive and Neuroimaging Variables Associated With Response to Treatment in Patients With OCD[NCT03993535] | Phase 4 | 250 participants (Actual) | Interventional | 2018-10-10 | Active, not recruiting | ||
| An Open-Label Trial of Epidiolex in the Treatment of Obsessive Compulsive Disorder and Related Disorders: Proof of Concept Study[NCT04978428] | Phase 2 | 15 participants (Anticipated) | Interventional | 2022-04-14 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for clomipramine and Schizotypal Personality Disorder
| Article | Year |
|---|---|
Predictors of drug treatment response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Age of Onset; Clomipramine; Comorbidity; Fluoxetine; Follow-Up Studies; Humans; M | 1995 |
Predictors of drug treatment response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Age of Onset; Clomipramine; Comorbidity; Fluoxetine; Follow-Up Studies; Humans; M | 1995 |
Predictors of drug treatment response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Age of Onset; Clomipramine; Comorbidity; Fluoxetine; Follow-Up Studies; Humans; M | 1995 |
Predictors of drug treatment response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Age of Onset; Clomipramine; Comorbidity; Fluoxetine; Follow-Up Studies; Humans; M | 1995 |